Six New Cases of 22q13.2 Gain Including TFC20 : First Report of Triplication and Smallest Duplication Associated With Neurodevelopmental Delays
Clinical Genetics · 2025
DOI: 10.1111/cge.14781 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Genetics, 2025. Verfasst von Etienne Bizot und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pédiatrie, APHP.Hôpitaux Universitaires Paris Saclay, Clamart, France. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Chromosomes, Human, Pair 22, Chromosome Duplication, Developmental Disabilities. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Direction Générale de l'offre de Soins.
Abstract (Originalsprache)
To date, only one study describes three unrelated cases of neurodevelopmental disorders associated with duplications in 22q13.2, which include the TCF20 gene. In contrast, TCF20 variants and deletions are well characterized. Here, we report six new cases of 22q13.2 gain, including TCF20 , identified through array‐comparative genomic hybridization (array‐CGH). Probands exhibited neurodevelopmental delay, and several presented with facial dysmorphism, abnormal growth parameters, and abnormalities affecting the skeletal, respiratory, genitourinary, and/or cardiovascular systems. We documented one 440 Kb triplication and five cases of duplication ranging from 82.5 Kb to 3.03 Mb in size. Co‐segregation analysis of the CNV and clinical symptoms supports variable expressivity. However, the complete penetrance of these gains remains questionable compared to the known pathogenic variants and structural variations associated with loss of function. We discuss the genotype–phenotype correlations and hypotheses surrounding the impairment of TCF20 protein function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pédiatrie, APHP.Hôpitaux Universitaires Paris Saclay, Clamart, France.
- Médecine Génomique et Pharmacogénomique, APHP.Hôpitaux Universitaires Paris Saclay, Clamart, France.
- Université Bordeaux, MRGM INSERM U1211, CHU de Bordeaux, Génétique Médicale, Bordeaux, France.
- Genetic Health Service NZ (Northern Hub), Te Toka Tumai, Auckland, New Zealand.
- Neuropédiatrie, APHP.Hôpitaux Universitaires Paris Saclay, Le Kremlin Bicêtre, France.
- Faculté de Médecine-Université Paris-Saclay, Le Kremlin Bicêtre, France.
ORCID-Profile: Etienne Bizot
Förderung
- Direction Générale de l'offre de Soins
Zitieren
APA
Bizot, E., Jouni, D., Rooryck, C., Taylor, J., Legendre, M., Charbonnier, L., Metreau, J., Benaloun, E., Pinson, A., Quenum, G., Bouligand, J., Tachdjian, G., Labrune, P., & Tosca, L. (2025). Six New Cases of 22q13.2 Gain Including TFC20 : First Report of Triplication and Smallest Duplication Associated With Neurodevelopmental Delays. Clinical Genetics. https://doi.org/10.1111/cge.14781
Vancouver
Bizot E, Jouni D, Rooryck C, Taylor J, Legendre M, Charbonnier L, et al. Six New Cases of 22q13.2 Gain Including TFC20 : First Report of Triplication and Smallest Duplication Associated With Neurodevelopmental Delays. Clinical Genetics. 2025. doi:10.1111/cge.14781
BibTeX
@article{Bizot2025,
author = {Bizot, Etienne and Jouni, Dima and Rooryck, Caroline and Taylor, Juliet and Legendre, Marine and Charbonnier, Lorelei and Metreau, Julia and Benaloun, Emmanuelle and Pinson, Audrey and Quenum, Geneviève and Bouligand, Jérôme and Tachdjian, Gérard and Labrune, Philippe and Tosca, Lucie},
title = {Six New Cases of 22q13.2 Gain Including TFC20 : First Report of Triplication and Smallest Duplication Associated With Neurodevelopmental Delays},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14781}
}
EUVIMED